-+ 0.00%
-+ 0.00%
-+ 0.00%

ROCHE RECEIVES FDA CLEARANCE FOR ELECSYS® PTAU217, ADVANCING ALZHEIMER'S DISEASE ASSESSMENT ACROSS PRIMARY AND SPECIALTY CARE

Reuters·08/24/2026 11:00:07

Please log in to view news